Image 1
Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 0093-7164
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 0093-7164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a product label for Tolterodine Tartrate Extended-Release medication with product information such as the GTIN: 0030937163565, the issue date (82016), and the batch number (323K221620417). It is used to treat symptoms of an overactive bladder.*
Image 3
This is a prescription drug with the name Iterodine Tartrate, which comes in an extended-release form. The National Drug Code assigned to it is NDC 0093-7164-56. However, the remaining information is unclear and not available for comprehension.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
